Lease of Manufacturing Facility

Summary by AI BETAClose X

4basebio PLC is expanding its operations with the lease of a new 26,500 square foot innovation hub and manufacturing facility in Cambridge, UK, expected to be operational by late summer 2026. This expansion, which includes 7,500 square feet of specialized laboratory space and an additional 7,500 square feet for future growth, is designed to meet the increasing demand for high-quality synthetic DNA crucial for next-generation therapeutics such as mRNA vaccines, gene and cell therapies, and genome editing. The new facility will enhance the company's capacity to support clients advancing drug development through clinical phases, reinforcing its position as a key partner in the life sciences ecosystem.

Disclaimer*

Companies

4basebio (4BB)
UK 100

Latest directors dealings